In this issue:
- Cost-effectiveness of as-needed budesonide/formoterol vs. low-dose ICS maintenance for mild asthma
- Patients’ perspectives of maintenance vs. as-needed preventers for mild asthma
- Worldwide trends in asthma symptom burden among school-aged children
- Socioeconomic biases in asthma control and specialist referral of possible severe asthma
- Oral steroid stewardship for asthma in adults and adolescents
- Expert consensus on oral steroid tapering in asthma
- Personalised oral steroid elimination with benralizumab in severe eosinophilic asthma
- Impact of UK COVID-19 lockdown on asthma exacerbations
- Airway microbiota modulates azithromycin effect for recurrent asthma-like symptoms in preschoolers
- Stopping vs. continuing long-term mepolizumab for severe eosinophilic asthma
- Mepolizumab for chronic rhinosinusitis with nasal polyps
- Accelerated lung function decline in adults with remitted childhood asthma
Please login below to download this issue (PDF)